Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
The Simplify Health Care ETF (PINK +2.58%) provides active management and broad sector exposure, while the VanEck Pharmaceutical ETF (PPH +1.20%) offers a lower-cost, concentrated index of global pharmaceutical leaders. Investors seeking healthcare…
Urogen Pharma (NASDAQ:URGN) Stock Has Consensus Price Target of $52.38 According to Analysts
Shares of Urogen Pharma (NASDAQ:URGN - Get Free Report) have been given an average recommendation of 'Moderate Buy' by the ten brokerages that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a…
Here are the 6 big things we're watching in the stock market this week
Earnings season ramps up this week, with four Club holdings set to report. Two main inflation reports are also out. We tend to place more emphasis on what management teams say during post-release conference calls than on monthly economic data…
Prediction: My Top 2 Stocks to Buy Now Will Outperform the Stock Market Over the Next Decade
Winners tend to keep on winning. This is a core principle of my investing philosophy that's helped me generate market-crushing returns for investors who've followed along with my stock picks. More importantly, I believe this principle can help you…
HLB resubmits FDA application for liver cancer treatment
Korean drugmaker HLB has resubmitted its application for U.S. approval of a combination therapy for advanced liver cancer, renewing its push to bring the target treatment to market after addressing regulatory concerns raised earlier this year. The…
Early gains wiped out: Nifty slides below 22,400 as IT, FMCG and banking drag markets lower
Equity benchmarks reversed their early gains sharply by mid-session on Monday, with the Nifty 50 falling 160.95 points or 0.71 per cent to 22,359.50 and the Sensex dropping 599.44 points or 0.83 per cent to 71,872.89 as of 13.15 pm. Both indices…
HSBC leads global banks in facilitating Indian corporate fundraising across bonds, loans, and IPOs
HSBC has solidified its position as the premier international bank for Indian corporate fundraising, leading across G3 bonds, syndicated loans, and initial public offerings in the January-September 2026 period. HSBC was the leading international…
Stock Market Today Highlights: Stock markets tumble on oil price spike, foreign fund outflows; Sensex drops 548 points
Sensex Today, Nifty 50 | Stock Market Highlights: Erasing opening gains, the 30-share BSE Sensex tanked 547.65 points, or 0.76%, to settle at 71,924.68. The 50-share NSE Nifty dropped 157.10 points, or 0.70%, to end at 22,363.35. From the 30 Sensex…
Rupee gains 96 paise, but Nifty falls 157 points on crude, FII outflows
Indian equities closed lower on Monday as elevated crude oil prices, persistent foreign fund outflows and rising bond yields weighed on sentiment, offsetting the rupee's sharp appreciation against the US dollar. The Nifty 50 fell 157.10 points, or…
Nifty holds flat at open despite Wall Street gains; FII selling streak hits 11 sessions
Equity benchmarks opened on a cautious note on Monday with the Nifty 50 opening at 22,593.20 against a previous close of 22,520.45, and trading near 22,525.60, up just 5.15 points or 0.02 per cent, at 9.25 am. The Sensex opened at 72,771.32…
Merck & Co's US antibiotic withdrawal sends the wrong signals for combating resistance
A drug shortage notice posted on 9 September brought to light US pharma company Merck & Co's decision to discontinue its intravenous antibiotic combination Recarbrio in the US. Merck confirmed its decision to voluntarily stop manufacturing and…
DexCom (NASDAQ:DXCM) Stock Price Expected to Rise, BTIG Research Analyst Says
DexCom (NASDAQ:DXCM - Get Free Report) had its price objective boosted by equities research analysts at BTIG Research from $90.00 to $96.00 in a research note issued on Monday, Benzinga reports. The brokerage presently has a 'buy' rating on the…
Russell Brand is on trial for rape and sexual assault. His career has been a catalog of controversy
London (CNN) — British comedian and actor Russell Brand will stand trial in London on Monday, accused of rape and sexual assault. The 51-year-old has pleaded not guilty to three charges of rape, one charge of indecent assault and three…
Astrazeneca Plc (AZN) - What Are Researchers Saying About This Stock?
Astrazeneca Plc (NYSE:AZN - Get Free Report) has been assigned an average recommendation of 'Moderate Buy' from the eighteen analysts that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell…
Zenas BioPharma, Inc. (ZBIO) - What Are Analysts Thinking About This Stock?
Shares of Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) have been assigned an average recommendation of 'Moderate Buy' from the nine analysts that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with…
Receive a Daily briefing on Pharma Industry News
Get Started